Moving your injection day: the 48-hour and 72-hour rules

If you need to take a weekly injection early because of travel, approved drugs in the same receptor class define strict minimum intervals between consecutive doses. In the official Wegovy Patient Information for semaglutide, the day of weekly administration can be changed as long as the time between two doses is at least 2 days (48 hours). For tirzepatide (Zepbound, Section 2.2), the label requires at least 3 days (72 hours) between doses. The compound used in Catalyst protocols has a published elimination half-life of 5 to 7 days, similar to approved weekly medicines (where Section 12.3 records half-lives of about 5 days for tirzepatide and about 7 days for semaglutide). Injecting on day 5 instead of day 7 means a substantial portion of the previous dose is still circulating in your bloodstream, raising peak concentrations and increasing the chance of temporary digestive discomfort. The Catalyst app advises not taking doses close together. If travel forces a change, keep at least the 48-hour or 72-hour interval seen in approved classes, and confirm any schedule adjustment with your clinician.

Restarting after three weeks: washout math and label precedents

If you pause your weekly injections for three weeks (21 days), most of the circulating compound has cleared from your system. Based on the published half-life range of 5 to 7 days, 21 days represents between 3.0 and 4.2 elimination half-lives. This means only about 5% to 13% of your previous steady-state concentration remains in your body. For approved medicines in this class, official labels address prolonged interruptions directly. The prescribing information for Wegovy (Section 2.4) states that if 2 or more consecutive doses are missed, patients should reinitiate dosage escalation at a lower dosage to reduce the risk of gastrointestinal adverse reactions. By contrast, the Zepbound label carries no specific multi-week restart schedule, stating in Section 2.3 only that a missed dose should be taken within 4 days (96 hours) or skipped entirely. In the Catalyst app, the protocol screen gives you three distinct choices after a pause: resume at the exact milligram amount you paused at, restart at week 1, or pick an intermediate step from the protocol chooser. Because individual tolerance varies after a prolonged gap, consult your prescribing clinician to decide whether to resume at your held amount or reinitiate escalation at a lower step.